Transparency

Public funding and grants

The development of the T-Control® urinary catheter has been supported by national, regional and European public innovation programmes. The mandatory information for each action is published below.

2026

2026

Grant awarded

IPI Programme 2026

Rethink Medical has received support through the IPI programme to strengthen its innovation team and advance the development of a new catheterisation solution aimed at addressing complex urinary catheterisation situations.

Industrial Engineer Alba Jiménez Martel has joined the project to contribute to the design and development of a new catheter tip, including product-design and 3D-modelling activities.

Beneficiary
Rethink Medical, S.L.
Project
Development of an optimised catheter tip to expand the applicability of T-Control® in patients with complex urinary catheterisation
Grant awarded
€42,835.68
ESF+ co-financing
85%
Programme
Canary Islands ESF+ Programme 2021–2027
Funding body
Government of the Canary Islands
Co-funded by the European UnionMinistry of Labour and Social EconomyGovernment of the Canary Islands

2026

Grant awarded

Canarias Aporta PRE 2026

Rethink Medical has been awarded support through Canarias Aporta PRE 2026, a programme supporting internationalisation actions and projects undertaken by Canary Islands SMEs.

Beneficiary
Rethink Medical, S.L.
Programme
Canarias Aporta PRE 2026
Total subsidised project amount
€8,000.00
Grant awarded
€4,500.00
Purpose
Internationalisation

Earlier public funding

CDTI

“Innovative urinary catheter intended to reduce infections, improve patients’ quality of life and improve work efficiency in the hospital”.

Objective
Conducting international clinical trials and obtaining regulatory authorisation prior to marketing the T-Control® urinary catheter in the target markets.
Funding
Project funded by the Centre for the Development of Technology and Innovation (CDTI) through the aid programme for SMEs awarded the Seal of Excellence in the 2022 European Innovation Council (EIC) Accelerator under Horizon Europe, within the Recovery, Transformation and Resilience Plan – Next Generation EU.
Period
Start date: 01/07/2023 — End date: 30/06/2025
Budget
€2,235,500
Amount granted
€1,564,850
Final resolution (PDF)
CDTI, Recovery, Transformation and Resilience Plan and Next Generation EU logos

SODECAN

“Innovative urinary catheter intended to reduce infections, improve patients’ quality of life and improve work efficiency in the hospital”.

Objective
Manufacture and final moulding of the T-Control® urinary catheter; certification of the manufacturing process and product under ISO 13.485; preclinical validation of product usability, durability, leak-tightness, ageing and safety; pilot clinical trials; functional optimisation and development of the overall cost-effectiveness model; a ‘Best Practices Programme’ for healthcare professionals to improve use of the device.
Funding
Project financed through an ordinary loan under the ‘Business Innovation for SMEs’ line of the Canarias Financia 1 Fund, co-financed at 85% by the European Regional Development Fund (ERDF) through the Canary Islands ERDF Operational Programme 2014–2020, contributing to priority axis 1, ‘strengthening research, technological development and innovation’, and specific objective 1.2.1, ‘encouraging and promoting company-led research and innovation activities, supporting the creation and consolidation of innovative companies and supporting innovative public procurement’.
Period
Start date: 01/01/2022 — End date: 30/06/2023
Budget
€999,345
Amount granted
€849,443
SODECAN, Canarias Financia, ERDF, European Union and Government of the Canary Islands logos

INVESTIGO

T-Control®

Objective
Recruitment of a graduate to work with the R&D team on preclinical validation, preparation and conduct of clinical trials, and preparation of outreach materials and materials for scientific congresses.
Funding
Activity subsidised by the Canary Islands Employment Service through the Investigo Programme for recruiting young jobseekers to carry out research and innovation initiatives, within the Recovery, Transformation and Resilience Plan – Next Generation EU.
Period
Start date: 01/07/2022 — End date: 30/06/2023
Amount granted
€33,108.92
Investigo Programme, Canary Islands Employment Service and Next Generation EU logos

ENISA

T-Control® urinary catheter

Objective
Rethink Medical receives ENISA financing (Ministry of Industry, Trade and Tourism) through a participative loan.
Funding
Formalisation date: 23/09/2021
Amount granted
€195,000
ENISA logo

DIGINNOVA

Diginnova Programme

Objective
Rethink Medical announces its collaboration with the Fundación Canaria Universitaria de Las Palmas under the innovative Diginnova programme. The agreement signed on 14 July 2022 reinforces our commitment to promoting research and digital transformation in the Canary Islands.
Fundación Canaria Universitaria de Las Palmas (FULP) logo

2026

Grant awarded

DigiINNOVA 2026

Rethink Medical has been awarded support through the DigiINNOVA 2026 programme, supporting the company’s innovation and transformation activities.

2026

Grant awarded

Catalyza

Rethink Medical has been awarded support through the Catalyza programme, supporting new innovation and development activities within the company. The programme has allowed the company to incorporate interns into its team.

European recognition

4

European Commission Seals of Excellence

3 Horizon 2020 · 1 EIC Accelerator

Rethink Medical has received four Seals of Excellence from the European Commission for T-Control®-related innovation proposals: three through Horizon 2020 and one through the EIC Accelerator. These recognitions were awarded following competitive European evaluation processes and refer to the quality of the project proposals; they are not a clinical, performance or regulatory assessment of T-Control®.

View certificates

Horizon 2020

  • Seal of Excellence — Proposal 880134 — July 2019[HORIZON 2020 880134 CERTIFICATE REQUIRED]
  • Seal of Excellence — Proposal 946225 — November 2019[HORIZON 2020 946225 CERTIFICATE REQUIRED]
  • Seal of Excellence — Proposal 959145 — May 2020[HORIZON 2020 959145 CERTIFICATE REQUIRED]

EIC Accelerator

  • Seal of Excellence — EIC Accelerator — 2022[EIC ACCELERATOR 2022 CERTIFICATE REQUIRED]

Note

Funding publicity

Rethink Medical S.L. publishes this information in compliance with the communication and publicity obligations established by the funding bodies.

Last updated: August 2026